Corneal blindness is rising sharply in India, with an estimated 20,000 to 25,000 new cases annually. This adds to the existing 12 lakh cases, making corneal blindness one of the major contributors to vision loss, accounting for 7.5 per cent of the total blindness burden in the country.
Read MoreThe UK’s Medicines and Healthcare products Regulatory Agency has approved Eli Lilly's new treatment for early-stage Alzheimer’s disease, donanemab, marketed under the brand name Kisunla.
Read MoreHCG announced the launch of outpatient (OPD) consultations in Goa, expanding access to specialised cancer treatments for local patients. In collaboration with local hospitals.
Read MoreFortis Hospital Bannerghatta Road successfully treated a 16-year-old boy from Africa suffering from severe aplastic anaemia, a life-threatening condition where the bone marrow fails to produce sufficient blood cells.
Read MoreNiva Bupa Health Insurance, backed by private equity firm True North (formerly Max Bupa), has received final approval from the Securities and Exchange Board of India (SEBI) to raise Rs 3,000 crore through an initial public offering (IPO).
Read MoreThe Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP) has reached ₹1000 crore in sales by October 2024, significantly earlier than last year, when this target was met in December. This milestone underscores the increasing public trust in affordable, high-quality medicines provided through the initiative.
Read MoreA patient-centric HMIS is designed with the active involvement of patients, healthcare providers, and administrators in mind. It moves away from traditional systems, which often emphasise data management and compliance, creating solutions that feel disconnected from the user. By prioritizing user experience, healthcare organisations can develop systems that are functional, intuitive, and accessible, ultimately improving the quality of care.
Read MoreNiva Bupa Health Insurance Company and Paras Healthcare have received regulatory approval from the Securities and Exchange Board of India (SEBI) to move forward with their Initial Public Offerings (IPOs). The approvals, granted on October 18, allow both companies to raise capital through a mix of fresh equity and Offer for Sale (OFS) components.
Read MoreRajiv Gandhi Cancer Institute & Research Centre (RGCIRC) hosted the 3rd International and 11th Annual Nursing Conference, ‘Nursicon 2024’. The two-day event brought together approximately 400 participants, including renowned international doctors, specialists, nurses, and healthcare professionals, recognising the indispensable role nurses play in cancer care.
Read MoreDeepinder Goyal, the co-founder and CEO of Zomato, has unveiled his latest personal venture, Continue—a startup dedicated to health tracking and mental well-being. Goyal, known for his interest in health optimisation, is now applying that passion to his own entrepreneurial journey.
Read More